CD300f is a potential therapeutic target for the treatment of food allergy

Allergy. 2020 Feb;75(2):471-474. doi: 10.1111/all.14034. Epub 2019 Oct 2.

Authors

Shino Uchida^{1

2}, Kumi Izawa¹, Tomoaki Ando¹, Hiromichi Yamada^{1

3}, Koichiro Uchida¹, Naoko Negishi¹, Ayako Kaitani¹, Akie Maehara¹, Masakazu Nagamine¹, Anna Kamei¹, Ayako Takamori¹, Keiko Maeda¹, Nobuhiro Nakano¹, Toshiaki Shimizu^{1

3}, Hideoki Ogawa¹, Ko Okumura¹, Akihito Nagahara^{1

2}, Sumio Watanabe^{1

2}, Jiro Kitaura¹

Affiliations

¹ Atopy Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
² Department of Gastroenterology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
³ Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

PMID: 31471969
DOI: 10.1111/all.14034

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antibodies / immunology
Ceramides / immunology
Ceramides / metabolism*
Disease Models, Animal
Food Hypersensitivity / metabolism*
Immunoglobulin E / blood
Immunoglobulin E / immunology
Intestinal Mucosa / immunology
Mast Cells / immunology
Mice
Mice, Knockout
Receptors, Immunologic / genetics
Receptors, Immunologic / metabolism*
Th2 Cells / drug effects
Th2 Cells / immunology

Substances

Antibodies
CLM-1 protein, mouse
Ceramides
Receptors, Immunologic
Immunoglobulin E

Grants and funding